CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
19.46
-0.37 (-1.87%)
At close: Mar 28, 2025, 4:00 PM
19.42
-0.04 (-0.18%)
After-hours: Mar 28, 2025, 4:59 PM EDT

Company Description

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting.

It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders designed to record and store EEG signals generated by the headband.

In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell, Inc.
CeriBell logo
Country United States
Founded 2014
IPO Date Oct 11, 2024
Industry Medical Devices
Sector Healthcare
Employees 281
CEO Xingjuan Chao

Contact Details

Address:
360 North Pastoria Avenue
Sunnyvale, California 94085
United States
Phone (800) 436-0826
Website ceribell.com

Stock Details

Ticker Symbol CBLL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001861107
ISIN Number US15678C1027
Employer ID 47-1785452
SIC Code 3845

Key Executives

Name Position
Dr. Xingjuan Chao Ph.D. Co-Founder, President, Chief Executive Officer and Director
Dr. Josef Parvizi M.D., Ph.D. Co-Founder, Chief Medical Advisor and Director
Scott Blumberg Chief Financial Officer
Dr. Raymond Woo Ph.D. Chief Technology Officer
Joshua Copp Chief Business Officer
Dan Rogy Senior Vice President of Operations
Louisa Daniels J.D., M.B.A. General Counsel
Sean Manni Senior Vice President of Sales
Brian P. Price Senior Vice President of Marketing
Kristie Rodenbush Chief People Officer

Latest SEC Filings

Date Type Title
Mar 14, 2025 8-K Current Report
Feb 25, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 25, 2025 10-K Annual Report
Feb 25, 2025 8-K Current Report
Feb 20, 2025 SCHEDULE 13G Filing
Feb 14, 2025 SCHEDULE 13G Filing
Feb 13, 2025 SCHEDULE 13G Filing
Feb 12, 2025 SCHEDULE 13G Filing
Feb 12, 2025 SCHEDULE 13G Filing
Jan 13, 2025 8-K Current Report